The global antihypertensive drugs market is anticipated to grow at a significant CAGR during the forecast period. The major factors that are expected to fuel the market during the forecast period include a surge in the incidence of hypertension across the globe. The rise in awareness related to complications associated with hypertension is also a major factor that boosts the growth of the market. Moreover, an increase in the geriatric population and sedentary lifestyle are some key causes of hypertension, which in turn, is accelerating the demand for antihypertensive drugs. However, patent expirations are anticipated to hinder the growth of the market. Furthermore, the rise in research related to antihypertensive drugs is expected to offer a lucrative opportunity during the forecast period. Moreover, an increase in the incidence rate of CVD, owing to the rise in prevalence of stroke, diabetes, and hypertension patients is expected to drive the market.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/anti-hypertensive-drug-market
Hypertension is defined as a long-term medical condition that is marked by the high pressure of blood in the arteries, which is persistently elevated. Antihypertensive drugs are used for the treatment of patients suffering from high blood pressure also known as hypertension. Hypertension is a major disorder accompanied by serious complications such as heart attack, heart failure, and dementia. Therefore, hypertension requires early diagnosis and treatment. Some of the drug class used for the treatment of hypertension include diuretics, ACE inhibitors, and vasodilators.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered
- Regions Covered- Globally
Competitive Landscape: Johnson & Johnson Services, Inc., Merck KGaA, and Daiichi Sankyo Co., Ltd., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominates the market in base year?
- Which segment and region will project fastest growth in the market?
- How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Antihypertensive Drugs Market Report by Segment
By Therapeutic Class
- Diuretics
- ACE Inhibitors
- Calcium Channel Blockers
- Vasodilators
- Beta-Adrenergic Blockers
- Others
By Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- Online Pharmacy
A full report of Antihypertensive Drugs Market is available at: https://www.omrglobal.com/industry-reports/anti-hypertensive-drug-market
Antihypertensive Drugs Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Johnson & Johnson Services, Inc.
- Merck KGaA
- Daiichi Sankyo Co., Ltd.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research